Cultivating New Opportunities: Short-Term Strategies for Long-Term Growth
On September 30, 2009 Foley’s 2009 Life Sciences Conference, explored new legal and regulatory issues, creative financing strategies, and business opportunities for the life sciences community.
Special Keynote Speaker – Joshua Boger, Ph.D.
This year Foley welcomed Joshua Boger, Ph.D., founder and retired-CEO of Vertex Pharmaceuticals Incorporated and immediate-past-chairman of BIO’s Board of Directors. A true industry champion, Dr. Boger has a comprehensive understanding of the legal, scientific, and financial aspects of running a biotech company. During his opening keynote, Dr. Boger presented The Impact of Health Care Reform on Investment & Innovation in the Life Sciences Industry.
Lunch Keynote Presentation — Foley hosted Dr. Thomas Novak, Head of Discovery Technologies, Roche Palo Alto, who addressed the impact of cellular therapeutics on diagnostic medicine and personalized therapeutics within the pharmaceutical industry.
During a full day of in-depth panel discussions, life sciences CEOs, entrepreneurs, venture capitalists, managers, and in-house counsel addressed:
Innovative deal structures for today’s economy
Big pharma update and partnering opportunities
Key indicators of value & success: what investors are looking for
Life Sciences Opportunities in India & China
Please see below for presentation hand-outs and information on our speakers.
Co-Location Information
Foley’s Life Sciences Conference co-located with the Emerging Technologies Conference.